Trademarkia Logo

Canada

C$
Trademark Search in Canada
TOLERO PHARMACEUTICALS DESIGN

View On IC.GC.CA

TOLERO PHARMACEUTICALS DESIGN
REGISTERED

on 28 Jun 2019

Last Applicant/ Owned by

SUMITOMO DAINIPPON PHARMA CO. LTD.

6-8, Doshomachi 2-chome, Chuo-ku, Osaka-shi, Osaka

JP

Serial Number

1828452 filed on 21st Mar 2017

Registration Number

TMA1033661 registered on 28th Jun 2019

Registration expiry Date

28th Jun 2029

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOttawa

ONTARIO

CA

K1P5Y6

TOLERO PHARMACEUTICALS DESIGN

Trademark usage description

providing medical information relating to pharmaceuticals pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations for t Read More

Classification Information

Class [005]
Pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the central nervous system, namely diseases of the brain, movement, ocular motility and spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy and Parkinson's disease and central nervous system infections; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the peripheral nervous system, namely amyotrophic lateral sclerosis, numbness, lightheadedness, dysuria and dyshidrosis; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the urogenital system, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the cardiovascular system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the metabolic system, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the renal system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the gastroenterological system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the ophthalmologic system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the dermatologic system, namely dermatitis, eczema, psoriasis, skin pigmentation diseases and sexually transmitted diseases; pharmaceutical preparations for the prevention and treatment of hematologic and oncologic disorders and diseases; pharmaceutical preparations for the prevention and treatment of psychiatric disorders and diseases, namely anxiety disorders, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Parkinson's disease, Alzheimer's disease, cerebral palsy, multiple sclerosis and seizures; pharmaceutical preparations for the prevention and treatment of allergic disorders and diseases and disorders and diseases of the immune system, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of connective tissue and joints, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures and cartilage injuries; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for use in chemotherapy

Classification kind code

11

Class [042]
Testing, inspection and research of pharmaceuticals

Classification kind code

11

Class [044]
Providing medical information relating to pharmaceuticals

Classification kind code

11

Mark Details

Serial Number

1828452

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 50
on 21st Nov 2018		Allowed
Submitted for opposition 51
on 21st Nov 2018		Allowance Notice Sent
Submitted for opposition 42
on 8th Aug 2018		Advertised
Submitted for opposition 26
on 19th Jul 2018		Approved
Submitted for opposition 27
on 29th May 2018		Approval Notice Sent
Submitted for opposition 22
on 2th Mar 2018		Search Recorded
Submitted for opposition 20
on 2th Mar 2018		Examiner's First Report
Submitted for opposition 31
on 27th Mar 2017		Formalized
Submitted for opposition 1
on 22nd Mar 2017		Created
Submitted for opposition 30
on 21st Mar 2017		Filed